Literature DB >> 24674828

Life after colectomy for fulminant Clostridium difficile colitis: a 7-year follow up study.

Kai B Dallas1, Audree Condren1, Celia M Divino2.   

Abstract

BACKGROUND: The long-term prognosis of patients undergoing colectomy for fulminant Clostridium difficile colitis has not been well studied. The authors present 7-year survival trends in such patients.
METHODS: Patients were identified through a pathologic database. Medical records were reviewed and follow-up phone calls made to determine relevant patient history, longevity, and quality of life.
RESULTS: The 61 patients identified had mean and median survival of 18.1 and 3.2 months, respectively, and 1-year, 2-year, 5-year, and 7-year mortality of 68.5%, 79.6%, 88.9%, and 90.7%, respectively. Previous C difficile infection, hypotension, requirement of vasopressors, mental status changes, elevated arterial lactate, decreased platelet counts, intubation, and longer duration on nonoperative therapy were associated with in-hospital mortality. There were no factors correlated with long-term survival.
CONCLUSIONS: Patients who require colectomy for fulminant C difficile colitis have a poor prognosis with poor long-term survival and significant morbidity. Although there are several factors associated with in-hospital mortality, there were no factors correlated with long-term survival.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colectomy; Fulminant Clostridium difficile colitis; Prognosis; Surgery; Survival

Mesh:

Year:  2014        PMID: 24674828     DOI: 10.1016/j.amjsurg.2013.04.008

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

Review 1.  Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection.

Authors:  L Patrick Schenck; Paul L Beck; Justin A MacDonald
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

2.  Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.

Authors:  Emily N Tixier; Elijah Verheyen; Ryan C Ungaro; Ari M Grinspan
Journal:  Aliment Pharmacol Ther       Date:  2019-10-14       Impact factor: 8.171

3.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

4.  Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.

Authors:  Si Xuan; Kenneth M Zangwill; Weiyi Ni; Junjie Ma; Joel W Hay
Journal:  J Gen Intern Med       Date:  2020-02-03       Impact factor: 5.128

Review 5.  Clostridium Difficile Infection from a Surgical Perspective.

Authors:  Andreas M Kaiser; Rachel Hogen; Liliana Bordeianou; Karim Alavi; Paul E Wise; Ranjan Sudan
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

6.  Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.

Authors:  Emily N Tixier; Elijah Verheyen; Yuying Luo; Lauren Tal Grinspan; Charles H Du; Ryan C Ungaro; Samantha Walsh; Ari M Grinspan
Journal:  Dig Dis Sci       Date:  2021-03-22       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.